This Study in Patients With Different Types of Cancer (Solid Tumours) Aims to Find a Safe Dose of Xentuzumab in Combination With Abemaciclib With or Without Hormonal Therapies. The Study Also Tests How Effective These Medicines Are in Patients With Lung and Breast Cancer

NCT03099174 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

133

Enrollment

INDUSTRY

Sponsor class

Conditions

Neoplasms
Breast Neoplasms

Interventions

DRUG: Xentuzumab
DRUG: Abemaciclib
DRUG: Letrozole
DRUG: Anastrozole
DRUG: Fulvestrant
DRUG: Abemaciclib

Sponsor

Boehringer Ingelheim